Application of [68Ga]Ga-NI-FAPI-04 PET/CT Imaging in Fibroblast Activation Protein Related Diseases

ConditionsTumor Cardiovascular Diseases Pulmonary Fibrosis Rheumatic Immune Diseases Involving Large Blood Vessels Hypertrophic Cardiomyopathy (HCM)Other Hypoxic and Fibroblast Activated Diseases

Trial statusRecruiting

Trial phasePhase 1, Phase 2

Trial typeInterventional

Biological sexAll

Age18-85

SponsorPeking Union Medical College Hospital

About this trial

The purpose of this study is to conduct clinical research on \[68Ga\] Ga-NI-FAPI-04 PET/CT imaging and further investigate its diagnostic value in fibroblast activation related diseases.

Eligibility criteria

Qualifiers

1: 18-85 years old

Disqualifiers

1: Pregnant or lactating women

Trial design

Treatments tested in this trial

Injection of 68Ga-NI-FAPI

Treatment groups

30 Participants

are divided into 1 treatment group

Locations

Peking Union Medical College Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College BeijingBeijing Municipality, China

Sponsors and collaborators

Peking Union Medical College Hospital

Lead sponsor

Source ClinicalTrials.gov